Inclusion Criteria:
  -  Diagnosis of GCA as classified according to protocol-specified criteria;
  -  Participants entering Period 1 must be receiving treatment with TCZ 8 mg/kg IV Q4W.
Exclusion Criteria:
  -  Treatment with any other investigational agent besides TCZ within 12 weeks (or 5 half-lives of the investigational drug, whichever is longer) prior to screening;
  -  Evidence of serious uncontrolled disease;
  -  Known active current or history of recurrent bacterial, viral, fungal, mycobacterial, or other infections;
  -  Active TB requiring treatment within the previous 3 years.